20-45891283-G-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000372484(CTSA):c.-43G>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00951 in 1,522,640 control chromosomes in the GnomAD database, including 696 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.014 ( 66 hom., cov: 33)
Exomes 𝑓: 0.0090 ( 630 hom. )
Consequence
CTSA
ENST00000372484 5_prime_UTR_premature_start_codon_gain
ENST00000372484 5_prime_UTR_premature_start_codon_gain
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.315
Genes affected
CTSA (HGNC:9251): (cathepsin A) This gene encodes a member of the peptidase S10 family of serine carboxypeptidases. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate two chains that comprise the heterodimeric active enzyme. This enzyme possesses deamidase, esterase and carboxypeptidase activities and acts as a scaffold in the lysosomal multienzyme complex. Mutations in this gene are associated with galactosialidosis. [provided by RefSeq, Nov 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.62).
BP6
Variant 20-45891283-G-T is Benign according to our data. Variant chr20-45891283-G-T is described in ClinVar as [Likely_benign]. Clinvar id is 338522.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.116 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
use as main transcript | n.45891283G>T | intergenic_region |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CTSA | ENST00000372484 | c.-43G>T | 5_prime_UTR_premature_start_codon_gain_variant | 1/15 | 1 | ENSP00000361562.3 | ||||
CTSA | ENST00000372484 | c.-43G>T | 5_prime_UTR_variant | 1/15 | 1 | ENSP00000361562.3 | ||||
CTSA | ENST00000677394 | c.-43G>T | 5_prime_UTR_premature_start_codon_gain_variant | 2/16 | ENSP00000504790.1 |
Frequencies
GnomAD3 genomes AF: 0.0140 AC: 2128AN: 152218Hom.: 66 Cov.: 33
GnomAD3 genomes
AF:
AC:
2128
AN:
152218
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0277 AC: 4251AN: 153190Hom.: 198 AF XY: 0.0254 AC XY: 2079AN XY: 81808
GnomAD3 exomes
AF:
AC:
4251
AN:
153190
Hom.:
AF XY:
AC XY:
2079
AN XY:
81808
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00902 AC: 12355AN: 1370304Hom.: 630 Cov.: 27 AF XY: 0.00934 AC XY: 6327AN XY: 677526
GnomAD4 exome
AF:
AC:
12355
AN:
1370304
Hom.:
Cov.:
27
AF XY:
AC XY:
6327
AN XY:
677526
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0139 AC: 2124AN: 152336Hom.: 66 Cov.: 33 AF XY: 0.0163 AC XY: 1211AN XY: 74480
GnomAD4 genome
AF:
AC:
2124
AN:
152336
Hom.:
Cov.:
33
AF XY:
AC XY:
1211
AN XY:
74480
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
270
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2Other:1
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not provided, no classification provided | in vitro | Seelig Lab, University of Washington | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 18, 2019 | - - |
Combined deficiency of sialidase AND beta galactosidase Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at